Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis

BACKGROUND/AIMS: Direct‐acting antivirals (DAAs) have been approved for hepatitis C virus (HCV) treatment in patients with end-stage renal disease (ESRD) on hemodialysis. Nevertheless, the complicated comedications and their potential drug-drug interactions (DDIs) with DAAs might limit clinical prac...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Po-Yao, Wei, Yu-Ju, Lee, Jia-Jung, Niu, Sheng-Wen, Huang, Jiun-Chi, Hsu, Cheng-Ting, Jang, Tyng-Yuan, Yeh, Ming-Lun, Huang, Ching-I, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Hsieh, Meng-Hsuan, Chen, Szu-Chia, Dai, Chia-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Chang, Jer-Ming, Hwang, Shang-Jyh, Chuang, Wan-Long, Huang, Chung-Feng, Chiu, Yi-Wen, Yu, Ming-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820195/
https://www.ncbi.nlm.nih.gov/pubmed/33317251
http://dx.doi.org/10.3350/cmh.2020.0180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820195/
https://www.ncbi.nlm.nih.gov/pubmed/33317251
http://dx.doi.org/10.3350/cmh.2020.0180

Ejemplares similares